The differences that matter
Dose magnitude: Epidiolex dosing runs 10–20 mg/kg/day — for a 30 kg child, 300–600 mg of CBD daily. Typical dispensary products would require heroic, expensive volumes to match; most families using dispensary CBD for epilepsy are dosing a fraction of the studied range, which may explain a 'CBD failed us' story. Consistency: pharmaceutical batch tolerance versus dispensary products that legally vary more (and hemp-market products that vary wildly). Monitoring: Epidiolex prescribing includes liver-enzyme surveillance — its label documents hepatic effects and interactions with clobazam and valproate that apply chemically to any high-dose CBD, dispensary-sourced or not. Insurance: Epidiolex is covered for approved syndromes; dispensaries are cash.
For the approved syndromes, the pharmaceutical path is the evidence-backed default. Dispensary products enter the picture for seizure types outside the approvals (where Epidiolex won't be covered), for adding low-dose THC/THCA under physician guidance, or where neurologist-supervised high-dose CBD via dispensary is the accessible option.
Run everything through the neurologist
Seizure medication changes are neurology's domain — abrupt anticonvulsant changes can be life-threatening, and high-dose CBD shifts blood levels of the drugs already on board (clobazam most famously). The functional setup most families land on: epileptologist manages the regimen, knows exactly what cannabis products are in play, labs get checked, and the state card (epilepsy qualifies everywhere; minors via caregiver registration) covers what the prescription pad can't.
Be wary of anyone — vendor or clinic — promising seizure freedom from artisanal products. The published response pattern is meaningful seizure reduction for a substantial minority, life-changing for some, ineffective for others. That's the honest baseline to plan around.
The information on this site is for educational purposes only and is not medical or legal advice. Cannabis use carries risks; consult a licensed physician about whether medical cannabis is appropriate for you. Federal status (as of June 2026): marijuana dispensed under state medical licenses and FDA-approved cannabis products are Schedule III controlled substances; all other marijuana remains Schedule I under U.S. federal law. Laws cited here change; confirm current rules with the linked primary sources before acting on them.